Form 4: Viemed Healthcare Executive Jeremy Trahan Reports Share Transactions

Viemed Healthcare's General Counsel, Jeremy Trahan, reported the vesting and disposition of restricted stock units and phantom share units on January 29, 2025.

Summary

• Jeremy Trahan, General Counsel at Viemed Healthcare, reported several transactions involving the company's stock on January 29, 2025.
• These transactions include the vesting of 10,774 restricted stock units (RSUs) and 3,592 phantom share units.
• A portion of the vested RSUs, specifically 3,841 shares, were withheld to cover tax obligations.
• The vesting of phantom shares resulted in the acquisition of 3,592 common shares and their simultaneous disposition for cash.
• The price per share for the transactions was $8.28, based on the market closing price on January 29, 2025.
• Following these transactions, Mr. Trahan directly owns 21,166 common shares.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine SEC Form 4 filing, which is standard practice for company insiders reporting transactions in their company's stock. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• Form 4 filings are a standard requirement for all publicly traded companies in the United States.
• The transactions reported are typical for executive compensation packages that include stock-based awards.
• The vesting schedule of three equal annual installments is a common practice for equity grants.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of standard executive compensation practices.
• The filing provides transparency to the market regarding insider transactions.

Key Dates

Keywords

Viemed Healthcare, Jeremy Trahan, restricted stock units, phantom share units, insider trading, stock vesting, Form 4, SEC filing